Reporting of randomized factorial trials was frequently inadequate

J Clin Epidemiol. 2020 Jan:117:52-59. doi: 10.1016/j.jclinepi.2019.09.018. Epub 2019 Oct 1.

Abstract

Objectives: Factorial designs can allow efficient evaluation of multiple treatments within a single trial. We evaluated the design, analysis, and reporting in a sample of factorial trials.

Study design and setting: Review of 2 × 2 factorial trials evaluating health-related interventions and outcomes in humans. Using Medline, we identified articles published between January 2015 and March 2018. We randomly selected 100 articles for inclusion.

Results: Most trials (78%) did not provide a rationale for using a factorial design. Only 63 trials (63%) assessed the interaction for the primary outcome, and 39/63 (62%) made a further assessment for at least one secondary outcome. 12/63 trials (19%) identified a significant interaction for the primary outcome and 16/39 trials (41%) for at least one secondary outcome. Inappropriate methods of analysis to protect against potential negative effects from interactions were common, with 18 trials (18%) choosing the analysis method based on a preliminary test for interaction, and 13% (n = 10/75) of those conducting a factorial analysis including an interaction term in the model.

Conclusion: Reporting of factorial trials was often suboptimal, and assessment of interactions was poor. Investigators often used inappropriate methods of analysis to try to protect against adverse effects of interactions.

Keywords: Clinical trial; Factorial trial; Interaction; Randomized trial.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Clinical Trials as Topic / classification
  • Clinical Trials as Topic / standards*
  • Clinical Trials as Topic / statistics & numerical data
  • Data Interpretation, Statistical
  • Humans
  • Research Design / standards*